Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer | |
Cao, Hongxin; Dong, Wei; Shen, Hongchang; Xu, Jun; Zhu, Linhai; Liu, Qi; Du, Jiajun | |
刊名 | PLOS ONE |
2015 | |
卷号 | 10期号:8 |
DOI | 10.1371/journal.pone.0135844 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4776195 |
专题 | 山东大学 |
作者单位 | Shandong Univ, Shandong Prov Hosp, Inst Oncol, Jinan 250100, Peo |
推荐引用方式 GB/T 7714 | Cao, Hongxin,Dong, Wei,Shen, Hongchang,et al. Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer[J]. PLOS ONE,2015,10(8). |
APA | Cao, Hongxin.,Dong, Wei.,Shen, Hongchang.,Xu, Jun.,Zhu, Linhai.,...&Du, Jiajun.(2015).Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer.PLOS ONE,10(8). |
MLA | Cao, Hongxin,et al."Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer".PLOS ONE 10.8(2015). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论